explore -WSS

explore

author：comprehensive 2025-09-29 21:20:58 - browse：394

he exterior of the U.S. Capitol building is seen at sunrise — Sarah Silbiger/Getty Images

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills.

The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today. The policies are not identical, but at least three PBM reforms have been passed by panels in both chambers:

One that would replace PBM fees that are tied to a percentage of drug prices with flat fees
Another that would require Medicare to create standard performance measures on which PBMs base pharmacy payments
A third that would require PBMs to report a host of information, including drug costs, savings, beneficiary out-of-pocket costs, payments to pharmacies, and the amount of business directed to PBM-owned pharmacies

The Energy & Commerce subcommittee also passed other bills that mirror legislation that Senate Finance also has passed. That includes legislation to ensure seniors pay no more for drugs than insurers, and a measure that lets insurers add less-expensive biosimilars to formularies mid-year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Mass General Brigham physicians react to latest merger step

Wikipedia

WSS

What the Wegovy shortage looks like for doctors — and for patients

How doctors and nurses shape Google's AI

Peter Marks talks Operation Warp Speed for Rare Diseases

European regulators recommend Amylyx's ALS drug be rejected

Pancreatic cancer is often deadly, but new discoveries are raising hope

Multiple sclerosis has subtypes with different best treatments: study

knowledge

explore

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

How doctors and nurses shape Google's AI

Psychedelics group wrestles with new pharma identity

UnitedHealth, in a surprise, takes aim at Steward’s physician group

State Dept. review finds Biden bears some blame for Afghanistan failures

Nick Jonas talks about managing diabetes along with his career

Dobbs anniversary: the lost opportunity of abortion as health care

How clinical AI models' predictive power can degrade over time

Activists slam private health insurers over coverage restrictions

Overprescribed: High cost isn't America's only drug problem

leisure time

Pancreatic cancer is often deadly, but new discoveries are raising hope

Medicare to cover more brain scans related to Alzheimer’s drugs

People with mental disorders often marry others with same

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Medicare Advantage 2025 payments will dip, Biden administration says

Florida Supreme Court upholds state's abortion ban

focus

Wikipedia

Wikipedia

entertainment